Purification of mupirocin
Details for Australian Patent Application No. 2006215708 (hide)
International Classifications
Event Publications
30 August 2007 PCT application entered the National Phase
PCT publication WO2006/087237 Priority application(s): WO2006/087237
13 November 2008 Alteration of Name
The name of the applicant has been altered to Axellia Pharmaceuticals ApS
21 October 2010 Alteration of Name
The name of the applicant has been altered to Xellia Pharmaceuticals ApS
27 January 2011 Application Accepted
Published as AU-B-2006215708
26 May 2011 Standard Patent Sealed
5 July 2012 Assignment Registered
Xellia Pharmaceuticals ApS The patent has been assigned to Syngen Biotech Co., Ltd
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser